NCT01695070View on ClinicalTrials.gov

Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Fetal Growth Retardation
Interventions
DRUG

Melatonin

4mg prolonged release melatonin oral tablets twice daily

Trial Locations (1)

3168

Southern Health: Monash Medical Centre and Jessie McPherson Private Hospital, Clayton

All Listed Sponsors
lead

Monash University

OTHER

NCT01695070 - Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies | Biotech Hunter | Biotech Hunter